Laboratory

Vancouver — British Columbia has made remarkable progress in reducing HIV transmission and researchers now believe the province is closer than ever to achieving sustained control of new infections. To support this next stage, Genome British Columbia (Genome BC) is funding a new project that employs advanced genomic and artificial intelligence (AI) enabled tools to

Dr. Francis Mwimanzi started his CTN Mark Wainberg Postdoctoral Fellowship in the summer of 2022. A biomedical scientist who specializes in virology and immunology, Dr. Mwimanzi has embarked on a project to improve our understanding of the immune response to COVID-19 vaccines among people living with HIV. But how did he get to where he

In Ghana, remarkably diverse HIV strains cocirculate, but the full extent of this diversity remains unresolved. Faculty of Health Sciences (FHS) MSc student Anna Appah published a study examining HIV-1 subtype diversity in Ghana, increasing the country’s mere 31 full-genome HIV sequences in the public domain by over 200%. Up-to-date information on HIV diversity, subtype

People with suppressed HIV respond well to mRNA vaccines, but individuals with a low CD4 count may not be adequately protected. People living with HIV generally respond well to COVID-19 vaccines—especially if they receive booster shots—thereby dramatically reducing their risk of severe illness and death, according to several recent studies. But those with poorly controlled

A CITF-funded study, published in preprint, and not yet peer-reviewed, from Mark Brockman and Zabrina Brumme (Simon Fraser University and BC Centre for Excellence in HIV/AIDS), along with Drs. Aslam Anis and Marc Romney (University of British Columbia) showed that the antibody responses induced by a third dose of COVID-19 vaccine were as durable in

For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation. So says Dr. Ole Schmeltz Søgaard, Professor of Translational Viral Research at Aarhus University,